Home
About
Overview
Sharing Data
ORCID
Help
History (17)
The role of spiking and bursting pacemakers in the neuronal control of breathing.
Brighter eyes: combined upper cheek and tear trough augmentation: a systematic approach utilizing two complementary hyaluronic acid fillers.
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.
Translating behavioral health services research into benefits policy.
Renal cancer therapeutics: now what?
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Renal cancer therapeutics: now what?
Renal cancer therapeutics: now what? Oncology (Williston Park). 2012 Mar; 26(3):301, 304.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Renal Cell
Humans
Kidney Neoplasms
Molecular Targeted Therapy